Cannabis Law Report

MARCH 10, 2021

Marijuana Moment reports A Seattle doctor hoping to expand access to psilocybin mushrooms for terminally ill cancer patients is taking… Read More. The post USA: Dr Suing DEA Over Right To Give Patients Psilocybin Treatment first appeared on Cannabis Law Report.

DEA 85

DEA Treatment Patients Access 85

Cannabis Law Report

AUGUST 26, 2019

DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. The Agriculture Improvement Act of 2018, which was signed into law on Dec. Office of Public Affairs.

DEA 59

DEA Access Marijuana Programs 59

Cannabis Law Report

FEBRUARY 24, 2023

DEA extends many telemedicine flexibilities adopted during the COVID-19 PHE with appropriate safeguards WASHINGTON – Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 (..)

DEA 52

DEA Therapy Access Patients 52

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis. BRC) told The Cannigma this week. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

SpeedWeed

MARCH 11, 2021

“The case is about seeking to ensure that patients with serious, life-threatening illness are able to realize the promise of state and federal Right to Try laws and access psilocybin for therapeutic purposes.”. At that point, the team decided to sue the DEA to change its decision. “I

DEA 52

DEA Patients Access Advocacy 52

SpeedWeed

MAY 24, 2021

The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.

DEA 52

DEA Cultivation Research and Development Marijuana 52

Cannabis Law Report

MARCH 24, 2020

The DEA says the proposed rule will see additional registered growers and more diverse variety of marijuana strains available for research. Currently, the DEA has 37 pending applications to grow marijuana for research. DEA Publishes Notice of Proposed Rulemaking On Marijuana Research.

DEA 80

DEA Marijuana Extraction Strains 80

Veriheal

JANUARY 16, 2024

This occasion marks the first time that a federal agency has recommended rescheduling cannabis, and this could be the push the Drug Enforcement Administration (DEA) needs to finally make it happen. Individual states still determine this, leading to a confusing patchwork of laws and regulations around the country.

DEA 118

DEA Medicine Cannabis Legalization 118

Veriheal

NOVEMBER 11, 2023

According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Simply put, in the eyes of federal law, cannabis is illegal. According to Federal law, cannabis use is illegal. 5520), and the Veterans Equal Access Act (H.R.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

OCTOBER 4, 2021

In Attorney , Federal Law , Kathryn Tucker , Oregon , Psychedelics. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Access Pursuant to the Oregon Psilocybin Services Act. September 30, 2021. Kathryn Tucker.

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

DECEMBER 19, 2023

A new delta-8 study has revealed that people in states without access to legal cannabis products are far more likely to seek out and consume delta-8 and delta-9 variants, whether it be flower, edibles, or tinctures. The laws surrounding these products have some stipulations. Since hemp products must contain less than 0.3%

Legalization 111

Legalization Edibles DEA Access 111

NORML

MARCH 1, 2019

” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue.

DEA 160

DEA Research and Development Clinical Trials Marijuana 160

WeedAdvisor

JUNE 1, 2019

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis.

DEA 55

DEA Marijuana History Cannabis 55

CannaMD

SEPTEMBER 15, 2020

What law legalized medical marijuana in Florida? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. How does Florida law define medical marijuana? ” Translation?

Law 126

Law Marijuana Patients Treatment 126

SpeedWeed

JULY 13, 2021

Governor Polis is being faced with a lawsuit over House Bill 1317, a bill that negatively affected students who were meant to benefit from the law that allows cannabis use by medical patients in public schools. . Under this new bill, the law will require that doctors recommending medical cannabis can only do so from their scopes of practice.

Law 52

Law Patients DEA Access 52

Marijuana Lawyer Blog

JANUARY 12, 2019

Department of Justice, challenging the constitutionality of the federal law designating marijuana a Schedule I controlled substance proceeded recently to the next level with oral arguments before the U.S. Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government.

DEA 40

DEA Patients Epilepsy Medicine 40

Cannabis Law Report

JUNE 16, 2022

Federal law enforcement agents and their partners seized over 5.5 According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Program Statistical Report, agents and their partners confiscated approximately 5.53 million cultivated cannabis plants last year – a 20 percent increase over 2020’s totals.

DEA 52

DEA Marijuana Programs Data 52

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin. As such, the use, sale, and possession of psilocybin in the United States is illegal under federal law. have also passed “Right to Try” laws.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JUNE 11, 2021

Cannabis cannot be lawfully prescribed by physicians; physicians can only “recommend” its use to patients based on individual state laws that identify who qualifies as a patient for its use. Cannabis faces an overall lack of access to financial institutions as well as IRC 280E, and ketamine certainly does not. That’s about it though.

Law 104

Law Compliance Compliance DEA 104

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ? .

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 111

DEA Hemp Cultivation Advocacy 111

Cannabis Law Report

MARCH 30, 2022

NORML has long advocated for amending federal regulations so that federally-licensed scientists can directly access and assess the wide variety of cannabis products readily available in medical-use and adult-use state markets. The full text of S. 253 is online here. Additional information is available from NORML here.

Legislation 95

Legislation Clinical Trials DEA Access 95

Cannabis Law Report

MAY 10, 2022

Activists staged a demonstration outside of the Drug Enforcement Administration (DEA) headquarters in Virginia on Monday, demanding that the agency allow terminally ill patients to access psilocybin therapy. Marijuana Moment reports. DeaOutoftheway @RTTpsilocybin pic.twitter.com/1NJWt2cJWn. aeidinger) May 9, 2022.

DEA 52

DEA Therapy Access Patients 52

Cannabis Law Report

MARCH 7, 2020

In its performance budget submission to Congress for fiscal year 2021, DEA gave an overview of its enforcement efforts and made predictions about future trends. In its performance budget submission to Congress for fiscal year 2021, DEA gave an overview of its enforcement efforts and made predictions about future trends.

DEA 64

DEA THC Retail Access 64

Cannabis Law Report

JANUARY 16, 2020

In the following Q&A, Distinguished Professor of Criminal Justice Ralph Weisheit explains some of the finer points of the law. . Lawmakers have to come back, perhaps not having thought seriously about what that means, and build a law around this vague idea the people have supported.” .

Law 59

Law Legalization DEA Marijuana 59

Cannabis Law Report

NOVEMBER 2, 2022

Drug Enforcement Administration and the legal team representing terminally ill patients petitioning for access to psilocybin-assisted therapy. In late September, the DEA denied an official petition requesting that the agency look into rescheduling psilocybin from Schedule I to Schedule II.

Microdosing 52

Microdosing DEA Therapy Access 52

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

JULY 29, 2020

The case appears to be one of the first clashes between the California cannabis agency and federal agents over access to license-related records. California pushed … Read More.

DEA 59

DEA Access Cannabis 59

Veriheal

APRIL 11, 2022

federal law , it has not yet been used in any commonly prescribed medicines. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. federal law.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

DECEMBER 15, 2019

Domestic Hemp Production Program must be registered with the Drug Enforcement Administration (DEA) to handle controlled substances. The directory below summarizes hemp testing laboratories who are registered with the DEA. Click on image to access the directory. This directory is provided for informational purposes only.

Hemp 59

Hemp DEA Concentrates Programs 59

Canna Law Blog

AUGUST 16, 2022

As a refresher, the Drug Enforcement Administration (DEA) conducts the licensing process that enables researchers to gain access to cannabis product. The DEA still views cannabis as a controlled substance with “no known medical uses.” See: Not All Cannabis Reform is a Good Thing.).

DEA 66

DEA Access Cannabinoids Cannabis 66

Cannabis Law Report

JANUARY 13, 2022

In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. Below is a list of state law updates to look forward to this year. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. McGuireWoods LLP.

Dispensary 52

Dispensary Law Concentrates Patients 52

Cannabis Law Report

MAY 2, 2019

During a hearing Tuesday on eight VA health-related bills under consideration by Congress, VA officials told House lawmakers that as long as marijuana is illegal under federal law, the department cannot support legislation that promotes its role at the VA. One, the Veterans Equal Access Act, H.R. 1647, sponsored by Rep.

DEA 45

DEA Law Legislation Programs 45

NORML

JANUARY 15, 2020

Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. He continued: “The fact of the matter is that legalization and regulation work.

Policy 190

Policy DEA Legislation Data 190

Cannabis Law Report

FEBRUARY 28, 2022

Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. 1669, 1670 (2021) (arguing that patents on psychedelics may limit research, innovation, and public access). Glenn Cohen, Psychedelic Therapy: A Roadmap for Wider Acceptance and Utilization , 27 NATURE MED.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

FEBRUARY 6, 2019

AUTHOR: DARREN KAPLAN & GARRETT GRAFF – Hoban Law Group. PUBLISHER: CANNABIS LAW REPORT. Darren Kaplan and Garrett Graff Attorneys at Hoban Law Group. Department of Agriculture (USDA), not the Drug Enforcement Agency (DEA). It allows hemp farmers access to crop insurance, grants, and certification.

Law 40

Law Agriculture Compliance Compliance 40